Optimized cell-free synthesis of invasion plasmid antigen B and related compositions and methods of use
AssigneeVaxcyte, Inc.
InventorsNeeraj Kapoor, Jeffery C. Fairman
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a cell-free method for synthesizing an Invasion Plasmid Antigen B (IpaB) antigen associated with a Shigella bacterium comprising exogenous addition of the purified chaperone protein IpgC to the cell-free synthesis mixture. The disclosure further provides IpaB antigen mutants comprising non-natural amino acids incorporated during cell-free synthesis, enabling covalent conjugation to a Shigella O-antigen polysaccharide. Further provided are Ipa B antigens and conjugates thereof, as well as immunogenic compositions prepared with the synthesized IpaB antigens and conjugates thereof and methods of use.
Claims24
An Invasion Plasmid Antigen B (IpaB) polypeptide antigen comprising 3 or 4 non-natural amino acids (nnAA) incorporated into the IpaB polypeptide antigen amino acid sequence, wherein the nnAA is incorporated at position K395;
- at least one of positions K299 and K368, and a position selected from K289, K436, and K470 of SEQ ID NO:
- 1.
A method for expressing an Invasion Plasmid Antigen B (IpaB) polypeptide antigen from a Shigella bacterium comprising expressing the IpaB polypeptide antigen using cell-free protein synthesis in the presence of an exogenous IpgC chaperone protein.
Dependencies are inferred from the claim text.